AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32981857 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal ex vivo‐expanded WJ‐MSCs (10 × 10^6 cells)
Number of subjects: 10
Study 32981857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36416036 — intervention group
Group type: COMPARATOR
Intervention: InSurE
Number of subjects: 150
Study 36416036 — intervention group
Group type: EXPERIMENTAL
Intervention: LISA
Number of subjects: 150
Study 32259687 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable Non-Invasive Ventilation (pNIV)
Number of subjects: 24
Study 33412490 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative task-sharing model with enhanced mental health training and lay counselling referral service
Number of subjects: 1043
Study 33412490 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU) involving referral to PHC doctors and/or mental health specialists
Number of subjects: 1043
Study 32342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic compression at the thigh with lower inflation pressures
Number of subjects: 21
Study 32342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Phasic compression
Number of subjects: 21
Study 32342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic compression
Number of subjects: 21
Study 32342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential compression with narrow connection cuffs
Number of subjects: 21
Study 32342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflation pressures below 14 kPa
Number of subjects: 21
Study 35568312 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS (twice a day, 30-min, 3-mA) plus respiratory rehabilitation
Number of subjects: 56
Study 35568312 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS plus respiratory rehabilitation
Number of subjects: 56
Study 35568312 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 56
Study 35568312 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 56
Study 35568312 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS and Sham HD-tDCS
Number of subjects: 56
Study 33855355 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent two-drug regimens (2-DRs) given 4-5 days a week
Number of subjects: 85
Study 33855355 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuming the same 2-DR 7 days a week
Number of subjects: 85
Study 33855355 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent two-drug regimens (2-DRs)
Number of subjects: 85
Study 36260786 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment with 5-fluorouracil and folinic acid or capecitabine plus oxaliplatin (FOLFOX6 or CAPEOX; Arm 1)
Number of subjects: 0
Study 36260786 — intervention group
Group type: COMPARATOR
Intervention: Serial ctDNA surveillance with delayed adjuvant therapy (Arm 2)
Number of subjects: 0
Study 36260786 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX6/CAPEOX (Arm 3)
Number of subjects: 0
Study 36260786 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRINOX (Arm 4)
Number of subjects: 0
Study 34588245 — intervention group
Group type: EXPERIMENTAL
Intervention: eMMa (electronic medication management support system)
Number of subjects: 17200
Study 32041881 — intervention group
Group type: EXPERIMENTAL
Intervention: Δ9‐tetrahydrocannabinol (THC) intoxication
Number of subjects: 64
Study 32041881 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 64
Study 36288581 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based CBT with 6 phone calls (nurse support group)
Number of subjects: 60
Study 36288581 — intervention group
Group type: COMPARATOR
Intervention: Web-based CBT alone (control group)
Number of subjects: 60
Study 36288581 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse support group
Number of subjects: 60
Study 33824389 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 25
Study 33824389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 36038003 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 10 mg subcutaneously
Number of subjects: 46
Study 36038003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 34606933 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 0
Study 34606933 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33190355 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein intake at breakfast (10 g increase)
Number of subjects: 498
Study 33190355 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein intake at lunch (10 g increase)
Number of subjects: 498
Study 32962950 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulated screws (CS)
Number of subjects: 63
Study 32962950 — intervention group
Group type: COMPARATOR
Intervention: Screw plus reconstruction plate (SpRP)
Number of subjects: 63
Study 36112574 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-unexposed children
Number of subjects: 1920
Study 36112574 — intervention group
Group type: COMPARATOR
Intervention: HIV-exposed children
Number of subjects: 1920
Study 36112574 — intervention group
Group type: EXPERIMENTAL
Intervention: WGCFM score increase
Number of subjects: 1920
Study 34152666 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable accelerometer‐based navigation devices (PAD)
Number of subjects: 178
Study 34152666 — intervention group
Group type: COMPARATOR
Intervention: Conventional instrumentation (CON)
Number of subjects: 178
Study 36468897 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliary stent loaded with radioactive 125 I seeds (RBS)
Number of subjects: 196
Study 36468897 — intervention group
Group type: COMPARATOR
Intervention: Conventional biliary stent (CBS)
Number of subjects: 196
Study 32938772 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18140
Study 32938772 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18140
Study 32938772 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients post-discontinuation (≤30 days)
Number of subjects: 18140
Study 34491446 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical technique (MIST) or modified minimally invasive surgical technique (M-MIST)
Number of subjects: 47
Study 34491446 — intervention group
Group type: COMPARATOR
Intervention: Modified or simplified papilla preservation (MPP) or simplified papilla preservation technique (SPP)
Number of subjects: 47
Study 34491446 — intervention group
Group type: EXPERIMENTAL
Intervention: Early healing index (EHI) score
Number of subjects: 47
Study 616661423 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning
Number of subjects: 244
Study 616661423 — intervention group
Group type: EXPERIMENTAL
Intervention: curriculum-based self-study
Number of subjects: 244
Study 616661423 — intervention group
Group type: COMPARATOR
Intervention: seminar
Number of subjects: 244
Study 616661423 — intervention group
Group type: COMPARATOR
Intervention: lecture
Number of subjects: 244
Study 33356401 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796
Study 33356401 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study 32436409 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Uvuloplasty after Primary Palatoplasty
Number of subjects: 0
Study 32436409 — intervention group
Group type: EXPERIMENTAL
Intervention: Method for uvular repair during primary palatoplasty
Number of subjects: 0
Study 34996343 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic behavior therapy (TBT)
Number of subjects: 93
Study 34996343 — intervention group
Group type: COMPARATOR
Intervention: Behavioral activation (BA)
Number of subjects: 93
Study 33755280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 91
Study 33755280 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 91
Study 32379711 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-preventive care among TB patients
Number of subjects: 1600
Study 32379711 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness and attitudes towards TB
Number of subjects: 1600
Study 35410753 — intervention group
Group type: EXPERIMENTAL
Intervention: SID142 (200 mg cilostazol and 160 mg Ginkgo biloba leaf extract, once daily)
Number of subjects: 170
Study 35410753 — intervention group
Group type: COMPARATOR
Intervention: Renexin (cilostazol and Ginkgo biloba leaf extract, twice daily)
Number of subjects: 170
Study 35410753 — intervention group
Group type: EXPERIMENTAL
Intervention: SID142
Number of subjects: 170
Study 32780155 — intervention group
Group type: EXPERIMENTAL
Intervention: Ahlbäck classification
Number of subjects: 112
Study 32780155 — intervention group
Group type: EXPERIMENTAL
Intervention: Kellgren-Lawrence classification
Number of subjects: 112
Study 32780155 — intervention group
Group type: EXPERIMENTAL
Intervention: International Knee Documentation Committee (IKDC) classification
Number of subjects: 112
Study 32730216 — intervention group
Group type: EXPERIMENTAL
Intervention: RTSU-Net (relational approach with a novel non-local neural network module)
Number of subjects: 5470
Study 35131363 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 5 mg
Number of subjects: 1106
Study 35131363 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg
Number of subjects: 1106
Study 35131363 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg
Number of subjects: 1106
Study 35131363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1106
Study 33794293 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma tumor DNA detection
Number of subjects: 151
Study 33794293 — intervention group
Group type: EXPERIMENTAL
Intervention: TP53 gene alteration pre-treatment and at C2D1
Number of subjects: 151
Study 33794293 — intervention group
Group type: EXPERIMENTAL
Intervention: RB1 gene alteration pre-treatment and at C2D1
Number of subjects: 151
Study 33794293 — intervention group
Group type: EXPERIMENTAL
Intervention: PTEN gene alteration pre-treatment and at C2D1
Number of subjects: 151
Study 33794293 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who were positive pre-treatment and converted to undetectable
Number of subjects: 151
Study 33794293 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression samples with AR gain
Number of subjects: 151
Study 33338360 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status (SES)
Number of subjects: 0
Study 33338360 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower income and occupational class
Number of subjects: 0
Study 33338360 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education and higher income
Number of subjects: 0
Study 33338360 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower education
Number of subjects: 0
Study 33338360 — intervention group
Group type: EXPERIMENTAL
Intervention: SES variables
Number of subjects: 0
Study 36126310 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic complete fundoplication (LNF)
Number of subjects: 175
Study 36126310 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic partial fundoplication (LTF)
Number of subjects: 175
Study 36126310 — intervention group
Group type: COMPARATOR
Intervention: Control group (LTF)
Number of subjects: 175
Study 32046384 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 8
Study 32046384 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 8
Study 35557278 — intervention group
Group type: EXPERIMENTAL
Intervention: BAPN (300 mg/kg/day in water)
Number of subjects: 8
Study 35557278 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 8
Study 32760097 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor-control group (integrated motor control techniques with scapular strengthening exercises)
Number of subjects: 38
Study 32760097 — intervention group
Group type: COMPARATOR
Intervention: Regular-exercise group (conventional physical therapy and scapular muscle strengthening exercises)
Number of subjects: 38
Study 36109008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Citrate (SC, 500 mg/kg body mass)
Number of subjects: 16
Study 36109008 — intervention group
Group type: COMPARATOR
Intervention: Sodium Bicarbonate (SB, 300 mg/kg body mass)
Number of subjects: 16
Study 35665794 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete handover of anesthesia care to another clinician (n=908)
Number of subjects: 1817
Study 35665794 — intervention group
Group type: COMPARATOR
Intervention: No handover of anesthesia care (n=909)
Number of subjects: 1817
Study 35665794 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete handover of anesthesia care
Number of subjects: 1817
Study 35665794 — intervention group
Group type: COMPARATOR
Intervention: No handover of anesthesia care
Number of subjects: 1817
Study 32827501 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal AVP (20 IU)
Number of subjects: 101
Study 32827501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 36131289 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive therapy (iCBT) involving 7 weekly online modules delivered via a perinatal mental healthcare app
Number of subjects: 300
Study 36131289 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 300
Study 36131289 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive therapy (iCBT)
Number of subjects: 300
Study 34264766 — intervention group
Group type: EXPERIMENTAL
Intervention: 10.6 μm laser moxibustion (LM)
Number of subjects: 92
Study 34264766 — intervention group
Group type: COMPARATOR
Intervention: Traditional moxibustion (TM)
Number of subjects: 92
Study 35707385 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based educational intervention
Number of subjects: 0
Study 35707385 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 32810383 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg teneligliptin
Number of subjects: 127
Study 32810383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 35960044 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg intravenously during anesthesia induction, then continuously pumped at 1 mg/kg/h until operation)
Number of subjects: 40
Study 35960044 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline of equal volume)
Number of subjects: 40
Study 33548442 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous arteriovenous fistulas (p‐AVFs) created with the Ellipsys device
Number of subjects: 214
Study 33548442 — intervention group
Group type: COMPARATOR
Intervention: Surgical arteriovenous fistulas (s‐AVFs)
Number of subjects: 214
Study 33548442 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous arteriovenous fistulas (p‐AVFs)
Number of subjects: 214
Study 32039635 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Insomnia (BBTi)
Number of subjects: 62
Study 32039635 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring Control (SMC)
Number of subjects: 62
Study 32039635 — intervention group
Group type: COMPARATOR
Intervention: BBTi and SMC
Number of subjects: 62
Study 34320713 — intervention group
Group type: COMPARATOR
Intervention: Dexketoprofen
Number of subjects: 193
Study 34320713 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 193
Study 34320713 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 193
Study 34320713 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 193
Study 32663974 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 31
Study 32663974 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 31
Study 36163987 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib (PAC) 200mg BID
Number of subjects: 106
Study 36163987 — intervention group
Group type: COMPARATOR
Intervention: Ruxolitinib (RUX)
Number of subjects: 106
Study 36163987 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib (PAC)
Number of subjects: 106
Study 34232106 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient physician visit-days
Number of subjects: 69
Study 34232106 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory visit-days
Number of subjects: 69
Study 34232106 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiology visit-days
Number of subjects: 69
Study 34232106 — intervention group
Group type: EXPERIMENTAL
Intervention: Year of SSc diagnosis
Number of subjects: 69
Study 34232106 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate ratios for outpatient services
Number of subjects: 69
Study 34232106 — intervention group
Group type: COMPARATOR
Intervention: Non-SSc comparators
Number of subjects: 69
Study 33327231 — intervention group
Group type: EXPERIMENTAL
Intervention: CT angiogram (CTA) group (n=20)
Number of subjects: 60
Study 33327231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mimics group (n=20)
Number of subjects: 60
Study 33327231 — intervention group
Group type: EXPERIMENTAL
Intervention: CTA + mimics group (n=20)
Number of subjects: 60
Study 34533774 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline iron deficiency
Number of subjects: 2141
Study 34533774 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency at any yearly time point
Number of subjects: 2141
Study 33347383 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinto bean snack
Number of subjects: 26
Study 33347383 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea snack
Number of subjects: 26
Study 33347383 — intervention group
Group type: COMPARATOR
Intervention: Control snack (100% corn)
Number of subjects: 26
Study 33347383 — intervention group
Group type: COMPARATOR
Intervention: Whole yellow pea snack
Number of subjects: 26
Study 33347383 — intervention group
Group type: COMPARATOR
Intervention: Green lentil snack
Number of subjects: 26
Study 33347383 — intervention group
Group type: COMPARATOR
Intervention: Split yellow pea snack
Number of subjects: 26
Study 33347383 — intervention group
Group type: EXPERIMENTAL
Intervention: All snacks
Number of subjects: 26
Study 33513520 — intervention group
Group type: EXPERIMENTAL
Intervention: BRIMMS visual
Number of subjects: 24
Study 33513520 — intervention group
Group type: EXPERIMENTAL
Intervention: BRIMMS aural
Number of subjects: 24
Study 33513520 — intervention group
Group type: COMPARATOR
Intervention: Usual consultations
Number of subjects: 24
Study 33246430 — intervention group
Group type: EXPERIMENTAL
Intervention: Alberta FICare™ (n = 353 infants/308 mothers)
Number of subjects: 765
Study 33246430 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 365 infants/306 mothers)
Number of subjects: 765
Study 33246430 — intervention group
Group type: EXPERIMENTAL
Intervention: Alberta FICare™
Number of subjects: 765
Study 33246430 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 765
Study 35897097 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified procedure (30 patients)
Number of subjects: 84
Study 35897097 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bricker ileal conduit (54 patients)
Number of subjects: 84
Study 33605982 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft drusen volume in AMD eyes assessed by OCT
Number of subjects: 44
Study 33605982 — intervention group
Group type: COMPARATOR
Intervention: Cone density in donor eyes
Number of subjects: 44
Study 33605982 — intervention group
Group type: COMPARATOR
Intervention: Macular pigment optical density (MPOD)
Number of subjects: 44
Study 32188425 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchful observation (no PCI)
Number of subjects: 80
Study 32188425 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT) or whole brain radiotherapy (WBRT) for patients who develop brain metastases
Number of subjects: 80
Study 35508338 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate 20 mg/kg daily
Number of subjects: 182
Study 35508338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 32038026 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 2737
Study 32038026 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer sirolimus-eluting stent (DP-SES)
Number of subjects: 2737
Study 32038026 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month dual antiplatelet therapy (DAPT) after BP-SES implantation
Number of subjects: 2737
Study 32038026 — intervention group
Group type: COMPARATOR
Intervention: Twelve-month dual antiplatelet therapy (DAPT) after BP-SES implantation
Number of subjects: 2737
Study 34375541 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymorphic SSRs identified and validated using e‐PCR and capillary electrophoresis.
Number of subjects: 0
Study 34375541 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic diversity analysis using polymorphic SSRs.
Number of subjects: 0
Study 32173896 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy
Number of subjects: 192
Study 32173896 — intervention group
Group type: COMPARATOR
Intervention: Controls (n = 145)
Number of subjects: 192
Study 32173896 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with major depressive disorder
Number of subjects: 192
Study 36386386 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols oromucosal spray
Number of subjects: 34
Study 36386386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 32544773 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual stimuli
Number of subjects: 282
Study 32544773 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 282
Study 32544773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (C)
Number of subjects: 282
Study 32544773 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone x Cortisol interaction
Number of subjects: 282
Study 35171041 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic Hypericum C200 in addition to usual pain management
Number of subjects: 0
Study 35171041 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to usual pain management
Number of subjects: 0